Citations
2 publicationsPublications from researchers using this productDescription
Hypoxanthine is a metabolite of the purine catabolism pathway[1]. Hypoxanthine can be used as rapid and sensitive bio-marker for acute cardiac ischemia at an early stage[2]. Hypoxanthine acts as a substrate for xanthine oxidase and is associated with ROS (reactive oxygen species), which contribute to vascular dysfunction and atherosclerosis[1].
Hypoxanthine (1.5, 2mM; 2h) induced ROS generation and increased cholesterol levels in HepG2 cells[1].
Hypoxanthine (200mg/kg; 8weeks; p.o.) significantly increased the cholesterol ester levels in Apoe KO mice[1]. Hypoxanthine (135mg/kg; 3d; i.v.) consistently increased the brain infarct volume in C57BL/6J mice underwent middle cerebral artery occlusion surgery[3].
References:
[1] yu H M, Kim Y J, Oh E J, et al. Hypoxanthine induces cholesterol accumulation and incites atherosclerosis in apolipoprotein E-deficient mice and cells [J]. Journal of cellular and molecular medicine, 2016, 20(11): 2160-2172.
[2] Farthing D E, Farthing C A, Xi L. Inosine and hypoxanthine as novel biomarkers for cardiac ischemia: from bench to point-of-care [J]. Experimental biology and medicine, 2015, 240(6): 821-831.
[3] Ye J, Bi X, Deng S, et al. Hypoxanthine is a metabolic biomarker for inducing GSDME-dependent pyroptosis of endothelial cells during ischemic stroke [J]. Theranostics, 2024, 14(15): 6071-6087.
Protocol
| Cell experiment [1]: | |
|
Cell lines |
Human HepG2 hepatic carcinoma cells |
|
Preparation Method |
HepG2 cells were seeded at a density of 1×104 cells/well in a black 96-well plate. Cells were incubated with a solution of 50μM DCFH-DA (2’,7’-dichlorofluorescein diacetate) in serum-free medium for 30min. This was followed by washing the cells twice with PBS. The cells were then incubated with Hypoxanthine for 2h. Intracellular ROS levels were determined using a fluorescence microscope. |
|
Reaction Conditions |
1.5, 2mM; 2h |
|
Applications |
Hypoxanthine induced ROS generation in HepG2 cells. |
| Animal experiment [2]: | |
|
Animal models |
C57BL/6J mice |
|
Preparation Method |
Adult C57BL/6J mice were received middle cerebral artery occlusion (MCAO) surgery. Intravenous injection of Hypoxanthine (135mg/kg) was carried out from one day before MCAO to one day after MCAO. Infarct volume assessment by triphenyl tetrazolium chloride (TTC) staining. |
|
Dosage form |
135mg/kg; 3d; i.v. |
|
Applications |
Hypoxanthine consistently increased the brain infarct volume. |
References: [1] Ryu H M, Kim Y J, Oh E J, et al. Hypoxanthine induces cholesterol accumulation and incites atherosclerosis in apolipoprotein E-deficient mice and cells [J]. Journal of cellular and molecular medicine, 2016, 20(11): 2160-2172. [2] Ye J, Bi X, Deng S, et al. Hypoxanthine is a metabolic biomarker for inducing GSDME-dependent pyroptosis of endothelial cells during ischemic stroke [J]. Theranostics, 2024, 14(15): 6071-6087. | |
Product Documents
Chemical Properties
Use stock solutions within 6 months when stored at -80°C or within 1 month when stored at -20°C.
To improve solubility, warm the tube to 37°C and sonicate it for an appropriate period.
CalculatorsMolarity / Dilution / Molecular Weight / Unit Conversion / In Vivo Formulation / Solubility
Reviews
Review for Hypoxanthine
- 5 Star100%
- 4 Star0%
- 3 Star0%
- 2 Star0%
- 1 Star0%
